NAMSA ® Acquires Syntactx to Enhance End-to-End CRO Development Solutions, Expanding Medical Device Clinical Research Capabilities and Expertise

“Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device development and clinical research services,” stated Dr. Kenneth Ouriel, President and CEO of Syntactx.